Showing results (31-40 of 6,932) with videos related to
Sort By:
Pageof 694
World Journal of Diabetes|September 2, 2022
Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!Awadhesh Kumar Singh, Ritu SinghJournal of Indian Society of Periodontology|September 23, 2015
The periosteum eversion technique for coverage of denuded root surfaceAwadhesh Kumar Singh, Preeti KiranExpert Review of Clinical Pharmacology|January 7, 2016
Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidencesAwadhesh Kumar Singh, Ritu SinghIndian Journal of Endocrinology and Metabolism|December 23, 2015
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressAwadhesh Kumar Singh, Ritu SinghExpert Review of Clinical Pharmacology|March 1, 2016
Is gliclazide a sulfonylurea with difference? A review in 2016Awadhesh Kumar Singh, Ritu SinghExpert Review of Clinical Pharmacology|November 27, 2019
Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugsAwadhesh Kumar Singh, Ritu SinghSpectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 19, 2014
Superposition model study of Cr3+ doped tetra methyl ammonium cadmium chlorideRam Kripal, Awadhesh Kumar YadavExpert Review of Clinical Pharmacology|April 11, 2017
Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonistsAwadhesh Kumar Singh, Ritu SinghJournal of Clinical and Diagnostic Research : JCDR|March 10, 2017
Treatment of Periradicular Bone Defect by Periosteal Pedicle Graft as a Barrier Membrane and Demineralized Freeze-Dried Bone AllograftAwadhesh Kumar Singh, Anurag SaxenaWorld Journal of Diabetes|July 8, 2022
Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitorsAwadhesh Kumar Singh, Ritu SinghPageof 694